Adverse cutaneous effects of mitogen‐activated protein kinase inhibitors in children-Reference-Cited by-同舟云学术

Adverse cutaneous effects of mitogen‐activated protein kinase inhibitors in children

Published:2020-12-27 Issue:2 Volume:38 Page:420-423
ISSN:0736-8046
Container-title:Pediatric Dermatology
language:en
Short-container-title:Pediatr Dermatol

Author:

Dávila Osorio Victoria Lucia¹^ORCID,Vicente María Asunción¹^ORCID,Baselga Eulalia¹^ORCID,Salvador Hector²^ORCID,Cruz Ofelia²^ORCID,Prat Carolina¹^ORCID

Affiliation:

1. Department of Dermatology Hospital Sant Joan de Deu Barcelona Spain

2. Department of Oncology Hospital Sant Joan de Deu Barcelona Spain

Publisher

Wiley

Subject

Dermatology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/pde.14354

Reference10 articles.

1. Cutaneous reactions to targeted therapies in children with CNS tumors: A cross‐sectional study

2. Cutaneous Reactions in Children Treated with the Mitogen-Activated Protein Kinase Extracellular Signal-Regulated Kinase Inhibitor Trametinib for Neural Tumors

3. Single centre experience of cutaneous toxicity associated with braf and mek inhibitor treatment in children;Loka T;Arch Dis Childhood,2017

4. Cutaneous adverse effects of targeted therapies

5. Acneiform eruptions: A common cutaneous toxicity of the MEK inhibitor trametinib

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucocutaneous toxicities from MEK inhibitors: a scoping review of the literature;Supportive Care in Cancer;2024-08-23

2. Consensus recommendations on management of selumetinib-associated adverse events in pediatric patients with neurofibromatosis type 1 and plexiform neurofibromas;Neuro-Oncology Practice;2024-04-27

3. Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management;Journal of Clinical Medicine;2024-03-20

4. Cutaneous toxicities of mitogen-activated protein kinase inhibitors in children and young adults with neurofibromatosis-1;Journal of Neuro-Oncology;2024-03-05

5. Cutaneous Reactions in Pediatric Patients Treated with MEK Inhibitors: A Retrospective Single-Center Study;Dermatology;2024